Rossari Biotech Lists At Rs 670, A Premium of 58%
Speciality chemical maker Rossari Biotech made a strong debut on the bourses this morning. The stock listed at Rs 670 on the BSE, a premium of 57.65 per cent compared to the issue price of Rs 425 a share. At 10:12 am, the shares of Rossari Biotech were trading at Rs 674.60, higher by Rs 251 or 58.65 per cent, on the BSE.
Rossari Biotech is the first company to list during the lockdown and the second to debut after SBI Cards & Payment Services IPO in March this year.
The IPO had an issue price of Rs 423-Rs 425 per share. At the upper end of the price band, the offer for sale is estimated at Rs 446.25 crore.
The offer included a fresh issue of Rs 50 crore shares and an offer of sale (OFS) of 1.05 crore shares. A total of 50 per cent of the IPO was reserved for qualified institutional buyers, 15 per cent was for non-institutional investors and remaining portion of 35 per cent was reserved for retail investors.
Rossari Biotech's IPO was subscribed by more than 79 times. In contrast, the IPO of SBI Cards, the credit card arm of the country's largest lender State Bank of India, was subscribed more than 22 times.
The proceeds from Rossari Biotech IPO will be utilised for repayment/prepayment of loans, funding working capital requirements and general corporate purposes.
The Mumbai-based Rossari Biotech is a specialty chemicals manufacturer which has diversified into animal health and nutrition, home, personal care and performance chemicals markets.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.